Drug pipeline: 1Q12.

doi:10.1038/nbt.2210

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Drug pipeline: 1Q12.

Nature biotechnology - 7 May 2012

Mak Craig

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Commerce
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Approval

Share to Drug Industry

Share to United States

Share to United States Food and Drug Administration

Source

Open in PubMed

Identifiers

PMID: 22565954
DOI: 10.1038/nbt.2210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug pipeline: 1Q12.PMID 22565954Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read ↗

A single-cell atlas of DKD treatment responses.Semantic proximity Read ↗

[Pharmacogenomics].Semantic proximity Read ↗

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs.Semantic proximity Read ↗

KRAS: Druggable at Last.Semantic proximity Read ↗

DrugBank 5.0: a major update to the DrugBank database for 2018.Semantic proximity Read ↗

Using the HapMap in drug development.Semantic proximity Read ↗

PharmGKB summary: very important pharmacogene information for MT-RNR1.Semantic proximity Read ↗

Market watch: emerging companion diagnostics for cancer drugs.Semantic proximity Read ↗

Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.